Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 13.07B | 11.84B | 8.32B | 8.06B | 3.48B |
Gross Profit | 1.38B | 1.09B | 793.57M | 400.56M | 130.72M |
EBITDA | 1.26B | 1.08B | 750.92M | 738.91M | 112.75M |
Net Income | 853.74M | 598.77M | 374.90M | 702.83M | 106.12M |
Balance Sheet | |||||
Total Assets | 9.82B | 6.74B | 6.37B | 4.77B | 3.80B |
Cash, Cash Equivalents and Short-Term Investments | 2.86B | 2.33B | 1.79B | 1.66B | 1.63B |
Total Debt | 2.98B | 2.49B | 2.11B | 1.31B | 25.53M |
Total Liabilities | 6.63B | 4.05B | 4.13B | 2.78B | 2.06B |
Stockholders Equity | 3.01B | 2.49B | 2.02B | 1.76B | 1.75B |
Cash Flow | |||||
Free Cash Flow | 610.44M | 501.77M | -390.07M | 30.13M | 31.94M |
Operating Cash Flow | 629.44M | 517.91M | -383.80M | 30.97M | 42.83M |
Investing Cash Flow | -459.99M | -1.70B | -6.27M | 12.34M | -10.89M |
Financing Cash Flow | -164.01M | -27.05M | 512.66M | -43.33M | -156.81M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
67 Neutral | HK$21.75B | 25.48 | 31.05% | 1.97% | 10.46% | 42.58% | |
65 Neutral | $27.34B | 15.12 | -4.22% | 3.16% | 1.01% | 1.94% | |
$580.85B | 21.27 | 21.25% | 0.90% | ― | ― | ||
$7.94B | 554.05 | 0.21% | 3.42% | ― | ― | ||
$10.83B | 16.43 | 15.25% | 0.45% | ― | ― | ||
$39.31M | ― | -90.66% | ― | ― | ― | ||
53 Neutral | HK$78.27M | ― | -1.92% | ― | 20.02% | 90.55% |
China Tobacco International (HK) Company Limited announced an update on the expected timeline for the use of proceeds from its listing. As of the announcement date, approximately 53.5% of the net proceeds have been utilized, with HK$420.5 million remaining. The company has decided to extend the timeline for utilizing these funds to 2027, citing strategic investments, business growth, and international cooperation as key areas of focus. This extension reflects the company’s adaptive strategy in response to evolving market conditions, potentially impacting its operational efficiency and stakeholder interests.
China Tobacco International (HK) Company Limited held its Annual General Meeting (AGM) on June 20, 2025, where all proposed resolutions were passed by poll. Key resolutions included the approval of the company’s audited financial statements for 2024, the declaration of a final dividend of HK$0.31 per share, the re-election of directors, and the re-appointment of KPMG as auditors. The AGM also granted the directors mandates to issue and repurchase shares. These decisions are likely to strengthen the company’s governance and financial strategies, potentially impacting its market positioning and shareholder value positively.
China Tobacco International (HK) Company Limited has announced its upcoming annual general meeting (AGM) scheduled for June 20, 2025, in Hong Kong. Key agenda items include the consideration of the company’s audited financial statements for 2024, the declaration of a final dividend, re-election of directors, and re-appointment of KPMG as auditors. Additionally, a resolution will be proposed to grant the directors a mandate to issue and dispose of shares, limited to 20% of the total issued shares, which could impact the company’s capital structure and shareholder value.